India Cardiovascular Devices Market Growth Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The market encompasses a broad spectrum of medical devices used in the detection, monitoring, and treatment of cardiovascular conditions, ranging from electrocardiogram machines and echocardiography systems to coronary stents, implantable cardioverter defibrillators, and ventricular assist devices. India's market size is reported at approximately $1.6 billion to $2.3 billion in 2025, reflecting differences in estimation methodologies across sources. All major market projections agree on a compound annual growth rate between 6.6% and 7.2%, positioning the market to reach between $2.4 billion and $4.6 billion by 2030-2035, with the more conservative five-year forecasts landing near $2.4 billion.

• •Market valued at roughly $2.32 billion in 2025 with consistent ~7% annual growth across all major projections
• •Projected to reach $2.4 billion by 2030 under five-year forecasts and $4.1-5.8 billion under longer-dated projections
• •CAGR estimates range from 6.6% to 7.2%, reflecting strong underlying demand dynamics

India faces a severe and worsening cardiovascular disease burden, with lifestyle-related conditions such as coronary artery disease, hypertension, and diabetes driving a surge in demand for both diagnostic and therapeutic cardiac devices. An aging population, rising urbanization, dietary shifts, and sedentary lifestyles are compounding the incidence of heart disease across urban and rural populations alike. Government initiatives such as Ayushman Bharat, expanded medical insurance coverage, and increased public healthcare spending are improving access to cardiac care in previously underserved regions. The proliferation of specialty cardiac hospitals, catheterization laboratories, and interventional cardiology centers is further accelerating device adoption nationwide.

• •Cardiovascular disease accounts for roughly a quarter of all deaths in India, creating sustained demand across diagnostic and therapeutic device categories
• •Government health insurance programs and infrastructure expansion are broadening access to cardiac care in tier-2 and tier-3 cities
• •Growth in cardiac catheterization labs, interventional cardiology centers, and specialty hospital networks is driving procedural volumes higher

The market is broadly segmented into diagnostic and monitoring devices, including electrocardiographs, echocardiographs, and Holter monitors, alongside therapeutic and surgical devices such as stents, catheters, pacemakers, and heart valves. Interventional cardiology devices, including drug-eluting stents and balloon catheters, represent one of the largest and fastest-growing product segments given the volume of percutaneous coronary procedures performed annually. Demand is heavily concentrated in major metropolitan areas including Mumbai, Delhi, Bangalore, Chennai, and Hyderabad, which host leading cardiac hospitals and specialized treatment centers. Tier-2 cities and semi-urban centers are emerging as significant growth pockets as healthcare infrastructure expands and physician awareness of advanced cardiac technologies increases.

• •Product categories include diagnostic and monitoring devices alongside therapeutic and surgical devices covering stents, catheters, pacemakers, and valves
• •Interventional cardiology devices dominate the therapeutic segment due to high procedural volumes in coronary interventions
• •Major demand centers are in Mumbai, Delhi NCR, Bangalore, Chennai, and Hyderabad, with growing adoption in tier-2 cities

What are the recent trends and outlook?

The market is moving toward increased localization of manufacturing and supply chains, driven by government incentives, import substitution policies, and the cost advantages of domestic production. Price regulation and government-mandated capping on certain high-volume devices, particularly coronary stents, continue to pressure margins while simultaneously improving affordability and patient access at scale. Digital health integration, including remote cardiac monitoring and AI-assisted diagnostic tools, is beginning to reshape the competitive landscape as new entrants leverage software-enabled platforms. Continued expansion of hospital infrastructure, rising health insurance penetration, and the growing capabilities of Indian clinicians in complex interventional procedures underpin a positive long-term outlook, with mid-single-digit annual growth expected to persist through the coming decade.

• •Domestic manufacturing and supply chain localization are accelerating, supported by government policy and cost competitiveness
• •Price caps on select high-volume devices like coronary stents are improving access while compressing manufacturer margins
• •Remote cardiac monitoring and digital health platforms are emerging as a high-potential growth area within the broader market